Liu AB - Search Results

1

The role of inflammatory response and metabolic reprogramming in sepsis-associated acute kidney injury: mechanistic insights and therapeutic potential.

Liu AB, Tan B, Yang P, Tian N, Li JK, Wang SC, Yang LS, Ma L, Zhang JF. Liu AB, et al. Front Immunol. 2024 Oct 31;15:1487576. doi: 10.3389/fimmu.2024.1487576. eCollection 2024. Front Immunol. 2024. PMID: 39544947 Free PMC article. Review.

2

Current insight on the mechanisms of programmed cell death in sepsis-induced myocardial dysfunction.

Liu AB, Li SJ, Yu YY, Zhang JF, Ma L. Liu AB, et al. Front Cell Dev Biol. 2023 Dec 15;11:1309719. doi: 10.3389/fcell.2023.1309719. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 38161332 Free PMC article. Review.

3

Biological role and expression of translationally controlled tumor protein (TCTP) in tumorigenesis and development and its potential for targeted tumor therapy.

Liu AB, Liu J, Wang S, Ma L, Zhang JF. Liu AB, et al. Cancer Cell Int. 2024 Jun 4;24(1):198. doi: 10.1186/s12935-024-03355-9. Cancer Cell Int. 2024. PMID: 38835077 Free PMC article. Review.

4

The role and mechanism of pyroptosis and potential therapeutic targets in non-alcoholic fatty liver disease (NAFLD).

Li SJ, Liu AB, Yu YY, Ma JH. Li SJ, et al. Among authors: liu ab. Front Cell Dev Biol. 2024 Jul 3;12:1407738. doi: 10.3389/fcell.2024.1407738. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 39022762 Free PMC article. Review.

5

DDR1/2 enhance KIT activation and imatinib resistance of primary and secondary KIT mutants in gastrointestinal stromal tumors.

Liu A, Zhang S, Wang M, Zhang L, Xu S, Nasimian A, Li S, Zhao S, Cao X, Tian J, Yu Y, Fan Z, Xiao K, Zhao H, Kazi JU, Ma L, Sun J. Liu A, et al. Mol Carcinog. 2024 Jan;63(1):75-93. doi: 10.1002/mc.23637. Epub 2023 Sep 22. Mol Carcinog. 2024. PMID: 37737519

6

[D816V mutation of KIT specifically induces phosphorylation of HNRNPL and HNRNPK in COS-1 cells].

Zhang L, Zhang S, Fan Z, Jiang Z, Li S, Liu A, Sun J. Zhang L, et al. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2023 Feb;39(2):138-143. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2023. PMID: 36872432 Chinese.

7

Four and a half LIM domains 2 (FHL2) attenuates tumorigenesis of gastrointestinal stromal tumors (GISTs) by negatively regulating KIT signaling.

Zhang S, Zhang L, Zhang D, Guo Y, Gao Y, Jiang Z, Li S, Liu A, Cao X, Tian J, Zhao S, Yu Y, Yang W, Bai R, Huang L, Yan H, Zhao H, Sun J. Zhang S, et al. Mol Carcinog. 2024 Jul;63(7):1334-1348. doi: 10.1002/mc.23727. Epub 2024 Apr 17. Mol Carcinog. 2024. PMID: 38629424

8

Farnesyltransferase (FTase) Inhibitors Increase Inhibition of KIT Mutants by Imatinib.

Fan Z, Zhang L, Zhang S, Liu A, Li S, Cao X, Tian J, Zhao S, Sun J. Fan Z, et al. Rep Biochem Mol Biol. 2023 Apr;12(1):74-82. doi: 10.52547/rbmb.12.1.74. Rep Biochem Mol Biol. 2023. PMID: 37724142 Free PMC article.

9

SPRY4 inhibits and sensitizes the primary KIT mutants in gastrointestinal stromal tumors (GISTs) to imatinib.

Li S, Zhao S, Liang N, Zhang S, Zhang L, Zhou L, Liu A, Cao X, Tian J, Yu Y, Fan Z, Xiao K, Wang M, Zhao H, Bai R, Sun J. Li S, et al. Gastric Cancer. 2023 Sep;26(5):677-690. doi: 10.1007/s10120-023-01402-4. Epub 2023 May 24. Gastric Cancer. 2023. PMID: 37222910

10

Associations of the Charlson comorbidity index with depression and mortality among the U.S. adults.

Wang YZ, Xue C, Ma C, Liu AB. Wang YZ, et al. Among authors: liu ab. Front Public Health. 2024 Nov 27;12:1404270. doi: 10.3389/fpubh.2024.1404270. eCollection 2024. Front Public Health. 2024. PMID: 39664531 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

92 results

Search Page

Filters